Clinical Trial Update: Pharmacogenomics of antiVEGF in Patients With Age-Associated Macular Degeneration (AMD) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating pharmacogenomics of anti-VEGF therapy in patients with neovascular (wet) age-related macular degeneration is currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Neovascular Age-related Macular Degeneration

Snippet

Sponsor: Parc de Salut Mar | Conditions: Wet Age-related Macular Degeneration | Phase 3 | Status: RECRUITING